Vital Feat ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  14.8% 12.5% 16.3% 16.7% 18.6%  
Credit score (0-100)  15 19 10 9 7  
Credit rating  BB BB BB BB B  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -9.3 29.6 -3.5 7.2 27.6  
EBITDA  -9.3 29.6 -3.5 7.2 27.6  
EBIT  -9.3 29.6 -3.5 7.2 27.6  
Pre-tax profit (PTP)  -9.3 29.4 -3.8 6.2 26.1  
Net earnings  -9.3 24.9 -3.8 5.7 20.2  
Pre-tax profit without non-rec. items  -9.3 29.4 -3.8 6.2 26.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  14.9 44.8 41.0 46.7 66.9  
Interest-bearing liabilities  2.5 5.0 5.0 5.0 0.0  
Balance sheet total (assets)  17.4 62.2 46.0 52.5 75.9  

Net Debt  -13.8 -45.5 -38.8 -47.5 -75.9  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -9.3 29.6 -3.5 7.2 27.6  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 281.4%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  17 62 46 52 76  
Balance sheet change%  -40.2% 258.0% -26.1% 14.2% 44.7%  
Added value  -9.3 29.6 -3.5 7.2 27.6  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 1.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 100.0% 100.0% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -40.2% 74.3% -6.5% 14.7% 43.0%  
ROI %  -42.3% 88.0% -7.3% 14.8% 46.6%  
ROE %  -47.8% 83.5% -9.0% 13.0% 35.6%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  85.6% 72.0% 89.1% 89.0% 88.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  148.2% -153.9% 1,107.3% -655.6% -275.0%  
Gearing %  16.8% 11.2% 12.2% 10.7% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.4% 5.2% 6.9% 19.9% 62.2%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  7.0 3.0 9.0 9.1 8.4  
Current Ratio  7.0 3.6 9.2 9.1 8.4  
Cash and cash equivalent  16.3 50.5 43.8 52.5 75.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  14.9 44.8 41.0 46.7 66.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  -9 30 -4 7 28  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  -9 30 -4 7 28  
EBIT / employee  -9 30 -4 7 28  
Net earnings / employee  -9 25 -4 6 20